英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

alkahest    音标拼音: ['ælkəh,ɛst]
n. 万能溶剂

万能溶剂



安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home - Alkahest
    Alkahest, a Grifols subsidiary, is a research and drug discovery company mining the deepest layers of plasma knowledge to inform the development of potential transformative therapies and solutions for patients
  • Our Team - Alkahest
    Michael Bechauf is the Director of Software and Data Engineering at Alkahest, where he is responsible for providing a scalable data infrastructure and oversees the software engineering processes that ensure robust data analysis and real-world data (RWD) experience for the scientific teams
  • Contact - Alkahest
    Contact Corporate Headquarters Alkahest, Inc 125 Shoreway Road, Suite D San Carlos, CA 94070 Office: +1 (650) 801-0474 Fax: +1 (650) 801-0480 info@alkahest com
  • Board of Directors - Alkahest
    Karoly Nikolich is Chairman of the Board of Directors of Alkahest During the 1980s, he led Genentech’s entry into neuroscience and led and participated in the development of numerous protein therapeutics
  • The Science of Chronokines - Alkahest
    At Alkahest, we are decoding the plasma proteome to discover key proteins that increase or decrease with age, which we call chronokines
  • Careers - Alkahest
    At Alkahest, we explore the depths of plasma science to drive the development of potential transformative therapies for patients We’re driven – we love what we do – and work in a supportive and curious culture that fosters scientific innovation
  • Alkahest to Present New Data from Phase 2a Study of AKST4290 in . . .
    SAN CARLOS, Calif , July 15, 2019 (GLOBE NEWSWIRE) — Alkahest, Inc , a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced an oral presentation of data from its phase 2a study of AKST4290 (originally referred to as ALK4290) in neovascular age-related macular
  • Alkahest, Inc. Announces Key Appointment
    SAN CARLOS, Calif , — Alkahest Inc (“Alkahest”), a clinical-stage biotechnology company focused on developing new treatments for neurodegenerative diseases and other age-related conditions, announced today the appointment of Bruce Morimoto, PhD, as Vice President, Drug Development Operations
  • Alkahest Announces Multiple Presentations at the Society for . . .
    The Alkahest pipeline includes multiple therapeutic candidates ranging from selected plasma fractions to protein-targeted interventions which aim to slow the detrimental biological processes of aging





中文字典-英文字典  2005-2009